日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of Gαi3 as a promising target for osteosarcoma treatment

确定 Gαi3 是骨肉瘤治疗的一个有希望的靶点

Zheng-Jun Bian, Hua-Jian Shan, Yun-Rong Zhu, Ce Shi, Min-Bin Chen, Yu-Min Huang, Xiao-Dong Wang, Xiao-Zhong Zhou, Cong Cao

The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma

组蛋白乙酰转移酶 HBO1 在骨肉瘤中起着新的致癌基因的作用

Yan-Yang Gao, Zhuo-Yan Ling, Yun-Rong Zhu, Ce Shi, Yin Wang, Xiang-Yang Zhang, Zhi-Qing Zhang, Qin Jiang, Min-Bin Chen, Shuofei Yang, Cong Cao

Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma

鉴定线粒体 RNA 聚合酶作为骨肉瘤的潜在治疗靶点

Qi-Cai Han #, Xiang-Yang Zhang #, Peng-Hui Yan #, Song-Feng Chen, Fei-Fei Liu, Yun-Rong Zhu, Qing Tian

The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells

靶向SphK1的microRNA-3677对人骨肉瘤细胞的治疗价值

Chen Yao, Jian-Wei Ruan, Yun-Rong Zhu, Fei Liu, Hui-Ming Wu, Yan Zhang, Qing Jiang

microRNA-135b expression silences Ppm1e to provoke AMPK activation and inhibit osteoblastoma cell proliferation

microRNA-135b 表达沉默 Ppm1e 以激发 AMPK 活化并抑制成骨细胞瘤细胞增殖

Zheng-Wei Li, Yun-Rong Zhu, Xiao-Zhong Zhou, Bao-Biao Zhuo, Xiao-Dong Wang

The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models

mTORC1/2 双重抑制剂 XL388 在临床前骨肉瘤模型中的抗癌活性

Yun-Rong Zhu, Xiao-Zhong Zhou, Lun-Qing Zhu, Chen Yao, Jian-Feng Fang, Feng Zhou, Xiong-Wei Deng, Yun-Qing Zhang

Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells

鉴定 DNA-PKcs 为骨肉瘤细胞对盐霉素的主要耐药因子

Yun-Fang Zhen, Song-Tao Li, Yun-Rong Zhu, Xiao-Dong Wang, Xiao-Zhong Zhou, Lun-Qing Zhu

Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma

新型双磷脂酰肌醇 3-激酶/哺乳动物雷帕霉素靶标抑制剂 NVP-BEZ235 对骨肉瘤的活性

Yun-Rong Zhu, Han Min, Jian-Feng Fang, Feng Zhou, Xiong-Wei Deng, Yun-Qing Zhang